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▼Fig. 2 Site-specific recombination systems (cre/loxP;
FRT/FLP) have become a powerful tool for a broad range
of applications in in vitro culture of yeast, plant and verte-
brate cells (Ref. 1). Depending on the position of specific
target sequences, action of the recombinases results in inte-
gration, excision or inversion of DNA. Certain applications
require a temporarily limited action of the relevant recom-
binase. This holds especially true for targeting genes by site-
specific integration where extended expression of recombi-
nase would result in subsequent excision reactions. Limited
action of recombinase is currently achieved by transient ex-
pression of the relevant gene (Ref. 2) or by electroporation
of the enzyme itself (Ref. 3). These methods have obvious
practical limitations. Part of these could be overcome using
estradiol-activatable fusion proteins consisting of cre and an
estrogen receptor moiety (Ref. 4). However, this approach
requires the constitutive expression of the fusion protein
and absolutely estrogen-free sera. It is therefore not appli-
cable to living organisms.
We have developed a simple strategy of generating cells
with an adjustable cre expression controlled by a tetracyclin
(TET) responsive promoter (Ref. 5). This promoter is regu-
lated by a co-expressed transactivator which is inactivated
by TET. The successful application of this conditional ex-
pression system requires the screening for single cell clones
in which the transferred gene is strictly regulated. Accord-
ing to our experience, the frequency of generating such
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cell clones is less than 1%, which reflects the number of
suitable integration sites within the host cell chromosomal
DNA.
To simplify the protocol for screening for cells with
strict TET-regulated expression, we combined the TET-
responsive expression system with a positive/negative se-
lection procedure (Fig. 1). Using this procedure, cell pop-
ulations can be generated that allow a precise and tight
conditional control of cre expression. The power of this
system is shown in five mixtures of cre-expressing trans-
fectants which were infected with a retroviral vector carry-
ing a loxP−neo−loxP cassette and cultivated in the absence
and presence of TET (Table 1). The excision ratio reflects
the level of cre activity. A comparison with control infec-
tion experiments shows the absence of cre function in the
presence of TET (absence of the bicistronic cre construct;
data not shown). If compared with a single positive se-
lection, the positive/negative selection procedure enhances
the excision ratio more than 100-fold (data not shown).
The time course of cre-mediated excision efficiency on a
chromosomal target was determined (Table 2). The TET-
mediated block of cre expression thus allows stable integra-
tion of loxP-flanked sequences which can be subsequently
excised by switching on cre expression by withdrawal of
TET. The data show that the positive/negative selection
approach in the bicistronic arrangement guarantees a fast
and simple approach for generation of cells with strictly
regulated expression of cre recombinase.
Protocol
105 NIH3T3 cells were cotransfected with 1 µg pTCH and
10 µg of pUHD15-1 using DNA−calcium phosphate copre-
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FIGURE 1. Scheme for generating cells with conditional cre expression. In pTCH, a derivative of pTBC (Ref. 6), the tTA promoter controls expression
of a bicistronic transcription unit (Ref. 7). Cre represents the first cistron, the second cistron encodes hygtk, a fusion protein of hygromycinB
phosphotransferase and thymidine kinase (tk) (a gift from C. Karreman). Cre-expressing cells are generated by co-transfection of NIH3T3 cells with pTCH
and pUHD15-1 encoding the TET-respressible transactivator TA (Ref. 5). By selection for hygromycinB-resistant cells in the absence of TET, transfectants
are isolated in which both TA and cre are stably integrated and expressed. To eliminate cell clones in which cre is expressed in the presence of TET −
which is frequently observed as a consequence of integration into unfavourable sites of host DNA − hygromycinB-resistant cells were cultivated in
presence of both TET and ganciclovir but in the absence of hygromycinB. Using this procedure, cells which still transcribe the bicistronic expression unit
are eliminated by counterselection against tk activity with ganciclovir. To further circumvent the survival of cells in which tk expression is repressed by
methylation, cells may be additionally exposed to 5-azacytidine. This was shown to be successful in two independent experiments (data not shown).
cipitation. Cells were selected for hygromycinB resistance
using 200 U/ml hygromycinB. For negative selection, mix-
tures of resistant cell clones (usually 30−60) were pooled,
cultivated in DME + TET (1 µg/ml) for 2 days and then culti-
vated in DME supplemented with ganciclovir (10 µM) and
TET for at least 2 weeks. After negative selection, cells were
grown in absence of TET and ganciclovir for 2 days and sub-
sequently switched to medium containing hygromycinB.
Table 1. Regulation of cre activity by tetracyclin (TET)
Clone mixtures G418 + TET G418 + hygromycinB Relative cre activation
M1 700 0 ≥700
M2 700 ≤10 ≥70
M3 840 0 ≥800
M4 100 0 ≥100
M5 100 0 ≥100
Clone mixtures (M1-M5) of pTCH/pUHD15-1 co-transfected NIH3T3 cells generated
according to the protocol (Fig. 1) were infected with pBPLNL (Fig. 2) in the presence or
absence of TET. Relative cre activity is given by the ratio of clone numbers obtained after
selection of infected cells with G418 + TET (absence of cre), G418 + hygromycinB (presence
of cre). The rate of excision was found to be significantly increased by G418 + hygromycinB
selection compared with G418 selection (data not shown). Selection pressure guarantees
sufficient cre expression during the course of the experiment
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FIGURE 2. pBPLNL was derived from pBabePuro (Ref. 8) by integration of a loxP−neo−loxP cassette. In the absence of cre, the vector confers
resistance to G418.
Table 2. Time course of cre activity on proviral
targets
No. of cells
Time (days) No. of resistant to
of cre cells resistant hygromycinB Excision
cexpression to hygromycinB + G418 (%)
0 114 26 77
2 280 27 90
7 720 20 97
31 960 20 98
pTCH/pUHD15-1 co-transfected cells wereselected according to
the protocol outlined (Fig. 1). The cells were infected with pBPLNL
and selected for integration of complete proviruses by growth in
presence of G418 and TET (absence of cre). After successful
selection, the cells were cultivated for 10 days in G418 and TET.
The time course of cre activity after removal of TET was
determined: on day resistant cells were directly seeded in medium
supplemented with G418 + hygromycinB or hygromycinB alone.
Specific excision is defined by the percentage of cell clones
obtained after selection in these media. In parallel, to allow cre
expression preliminary to selection, G418-resistant cells were
cultivated in absence of TET and G418 and in presence of
hygromycinB for the indicated times (2, 7 and 31 days) and
subsequently seeded in the selection media
(G418 + hygromycinB and hygromycinB).
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